White Collar Courier: Delivering News and Providing Guidance in White Collar Matters

Similar documents
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Law Enforcement and the Prescriber Enforcement Action Protocol

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

Pharmaceutical Diversion in Medicare. HHS Office of Inspector General: Background

Addiction, Pain, & Public Health website -

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Curbing Prescription Drug Abuse in Medicaid

A Bill Regular Session, 2015 SENATE BILL 717

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

Pennsylvania Prescription Drug Monitoring Program Trends,

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

Update on the Opioid Crisis

2017 NASCSA Conference

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose

Liability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians

Presentation Overview

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

High-Decile Prescribers: All Gain, No Pain?

Statement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.

Medicare Advantage Outreach and Education Bulletin

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

Crowe Healthcare Webinar Series

Review of Controlled Drugs and Substances Act

Community Health Group Compliance Training. Presented by Mike Scarano, esq. Foley & Lardner

Opioid Use and Other Trends

PRESCRIBING GUIDELINES

See Important Reminder at the end of this policy for important regulatory and legal information.

What is drug diversion?

COLLEGE OF PHYSICIANS AND SURGEONS OF NOVA SCOTIA SUMMARY OF DECISION OF INVESTIGATION COMMITTEE D. Dr. Deanna Swinamer

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

Health Care Compliance Association Pharmaceutical Diversion in Medicare

Behavioral Health in PACE: Substance Abuse

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Case 1:13-cr SCJ-JFK Document 1 Filed 01/22/13 Page 1 of 17 SEALED ATLANTA DIVISION

Changes to the Eighth Edition

Prescription Drugs: Issues in Treatment, Supervision and Case Management

See Important Reminder at the end of this policy for important regulatory and legal information.

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

Opioids drive continued increase in drug overdose deaths

Case 1:19-cv Document 1 Filed 04/23/19 Page 1 of 15

Legal Issues in Opioid Prescribing

MARYLAND BOARD OF PHARMACY

Prescription Drug Abuse Task Force Rx Report Card

Perspective from Kentucky: Using PMP Data in Drug Diversion Investigations

See Important Reminder at the end of this policy for important regulatory and legal information.

Pennsylvania s highest prescriber of pain medication arrested along with several patients in Lawrence County

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Guideline for the Rational Use of Controlled Drugs

Ontario s Narcotics Strategy

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Pharmacy Jurisprudence

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

See Important Reminder at the end of this policy for important regulatory and legal information.

ACCG Mental Health Summit

The Prescription Drug Overdose Epidemic

DRUG AND ALCOHOL POLICY

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

NC General Statutes - Chapter 90 Article 5E 1

Medicare Advantage Outreach and Education Bulletin

DEA: Combating the Supply

The Wisconsin Prescription Drug Monitoring Program

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

PDMP Tools to Identify Red Flag Situations

CDC s Approach to Addressing the Opioid Overdose Epidemic

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices

Prescription Audits: When the DEA or AG Come Knocking Anticipating and Responding to Heightened Investigations of Prescribing and Dispensing Practices

Education Program for Prescribers and Pharmacists

Do not open the test booklet prior to being told to do so.

POLICY ON DRUGS & ABUSE

The State of Maryland Executive Department

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

Risk Classification Modeling to Combat Opioid Abuse

Mark W. Caverly, Chief Liaison and Policy Section

Drug-free Workplace Staff Rights and Responsibilities

Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention

SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective

6/19/2012. Disappearing Drugs. Disappearing Drugs: Protect Yourself from Diversion. Disappearing Drugs: Protect Yourself from Diversion

Work Session VIII: Legalized Marijuana. Douglas J. Friednash City Attorney Denver, Colorado

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.

Prescribing Controlled Substances and the PDMP

University of Pittsburgh

The State of Cannabis in Oregon

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502)

Medication Guide. Medication Guide. Lazanda (La-ZAN-da) CII. (fentanyl) nasal spray 100 mcg, 400 mcg

6. Never give SUBSYS to anyone else, even if they have the same symptoms you have. It may harm them or even cause death.

Transcription:

White Collar Courier: Delivering News and Providing Guidance in White Collar Matters By Adam Overstreet The new DOJ initiative aggressively investigating and prosecuting pain management practitioners Part Three: Anatomy of a Pill Mill Investigation December 2017 In part one of this series, I detailed how the U.S. Department of Justice has focused its attention on the aggressive investigation and prosecution of pill mill cases. See Part One: DOJ Devotes Resources, Vows to Come After Pill Mills. In part two, I discussed what consequences doctors and other medical professionals could face as the result of a pill mill investigation. See Part Two: What s At Stake for Prescribing Professionals in Pill Mill Cases. In this installment, I give a detailed explanation of how the government investigates these cases. I. DATA ANALYSIS Pill mill investigations often start when the investigative agency 1 receives a tip for instance, from a competing doctor, a pharmacist, a patient, or a disgruntled former employee that a doctor is overprescribing drugs or drugs are being diverted from the practice (in other words, patients are diverting the drugs from their intended legitimate use for some illicit purpose, such as selling them on the street). Just as many investigations arise from data mining by investigators to uncover allegedly inappropriate prescribing patterns or doctors who are statistical outliers in terms of the type and amount of drugs they prescribe. In fact, in recently announcing the creation of the DOJ s new Opioid Fraud and Abuse Detection Unit, U.S. Attorney General Jeff Sessions stated that the unit s focus would be on opioid-related health care fraud using data to identify and prosecute individuals that are contributing to th[e] prescription opioid epidemic. 2 The following are examples of data sources that investigators use in investing pill mill cases. 1 The federal agencies who investigate pill mill cases include the DEA, the FBI, the Department of Health & Human Services Office of Inspector General, the Food & Drug Administration Office of Criminal Investigations, and the IRS Criminal Investigation Division (primarily regarding alleged money laundering and illegal kickback schemes). Various state agencies investigate these cases as well. 2 The full press release can be found here.

» PDMP Data Every state except Missouri has a prescription drug monitoring program ( PDMP ), an electronic database that tracks all controlled substance prescriptions statewide, based on information submitted by the dispensing pharmacy or doctor to a central clearinghouse. The PDMP data generally reflects the drug prescribed (type, strength, and quantity), the prescribing doctor, the patient, and the pharmacy at which the prescription was filled. Doctors can access this database for various purposes, such as pulling a patient s history of filling controlled drug prescriptions to determine if the patient is doctor shopping that is, getting multiple opioid prescriptions from multiple doctors at the same time. But the data is also accessible to investigators who use it, for example, to identify doctors who are writing high numbers of prescriptions for high doses of opioids or to determine whether doctors are prescribing repeated patterns of the same drugs or cocktails such as the Holy Trinity, a combination of an opioid, a carisoprodol (muscle relaxer), and a benzodiazepine (anti-anxiety drug), which the government maintains is a sure sign of an unscrupulous pill mill doctor. In addition to being a goldmine of information for investigators, prosecutors typically attempt to admit the PDMP data at trial. In the Mobile, Alabama pill mill case I helped prosecute (See Part One: DOJ Devotes Resources, Vows to Come After Pill Mills ), the government admitted PDMP data into evidence showing that during the four-year time period at issue, the two doctors wrote over 300,000 prescriptions for controlled drugs, including 6,000 prescriptions for TIRF drugs, a fentanyl-based 3 drug which the FDA has approved only for the treatment of breakthrough pain in cancer patients. The PMDP data also reflected that the doctors were the number one and two prescribers of fentanyl in the state.» ARCOS Data ARCOS (the Automation of Reports and Consolidated Orders System) is an automated, comprehensive drug reporting system the DEA maintains which monitors the flow of controlled substances from their point of manufacture through commercial distribution channels to point of sale or distribution at the dispensing / retail level. ARCOS accumulates these transactions, which are then summarized into reports. Investigators use these reports, for example, to identify pharmacies that are receiving unusually high volumes of controlled drugs. And, once again, prosecutors will attempt to admit this evidence at trial. In the Mobile, Alabama case, the government admitted ARCOS reports into evidence showing that one of the doctors was, for several consecutive years, the number one distributer in the state of oxycodone, morphine, and fentanyl. 3 Fentanyl is a particularly powerful narcotic painkiller (a schedule II controlled substance) which is reportedly 100 times more potent than morphine and 40-60 times more potent than pure heroin. It comes in various dispensing forms, including an oral spray, dissolvable tablet placed under the tongue, a buccal tablet placed in the cheek, and a nasal spray. 2

» Insurance Claims Data Investigators also regularly obtain claims data from Medicare, Medicaid, and private insurance companies such as Blue Cross Blue Shield to show that there are statistical outlier doctors who are billing these insurance companies for large amounts of opioids. In that vein, CMS (the Centers for Medicare & Medicaid Services) contracts with outside program integrity companies who monitor and analyze claims / billing data to uncover suspected Medicare and Medicaid fraud, waste, and abuse. The results of these audits are often shared with investigators. II. RECORD SEARCHES Investigators typically obtain the financial records of the pain management practice and its doctors in an effort to uncover evidence that the practice is a cash only business or the doctors are allegedly involved in illegal kickback and money laundering schemes (both of which were charged against the doctors in the Mobile, Alabama case). In addition, the government will use this financial data in an effort to locate, seize, and forfeit money and assets the doctors derived from the operation of their alleged pill mill. Investigators will also search disciplinary records to determine if the target doctor has a history of administrative discipline by the state medical board for allegedly inappropriate prescribing practices. III. SURVEILLANCE Investigators commonly utilize surveillance tactics to monitor the activities of street level drug dealers. And they have carried over these tactics to the investigation of alleged pill mills. Investigators will personally surveil the practice or install pole cameras video cameras installed on nearby utility poles to record activities at the practice around the clock. Investigators look for what they claim are sure signs of a pill mill operation, such as long lines of people standing outside the practice and leaving after only a short visit, or unusual hours of operation to allegedly cater to drug-seeking patients. Through surveillance, investigators also attempt to identify patients who may be willing to testify or provide evidence against the practice or participate in an undercover operation, as explained in the next section. IV. UNDERCOVER OPERATIONS A common investigative tactic in pill mill investigations is the use of undercover agents who pose as patients and schedule multiple appointments with the targeted pill mill doctor to obtain opioids. These meetings are secretly audio / video recorded. Some investigators opt to use actual, existing patients of the practice (if they are willing) to conduct these undercover meetings. The investigators analyze the recordings to determine if, for example, the doctor: met with the patient for a very short time period; failed to conduct a thorough physical exam and obtain a full medical history; failed to encourage alternatives to opioid treatment such as physical therapy; ignored signs of addiction; 3

suggested symptoms the patient should claim to feel; or instructed the patient to use a particular pharmacy. In the Mobile, Alabama case, the government presented evidence at trial that an undercover agent posed as a patient and had four appointments with one of the targeted doctors during a six-month period. During the initial visit, the patient told a pain clinic employee that he had been self-medicating with opioids he had bought on the street. Thereafter, the doctor met with the patient for 43 seconds and prescribed him 90 oxycodone pills. During each subsequent visit, which occurred approximately a month apart, the patient received similar opioid prescriptions without even being seen or treated by the doctor. V. ADMINISTRATIVE INSPECTIONS The DEA has a large cadre of diversion investigators ( DI s ) who have the authority to conduct administrative inspections of premises registered or regulated by the agency after giving proper notice to the registrant. DI s can use their authority to obtain an administrative inspection warrant ( AIW ) any time a registrant refuses to consent to an inspection or the DI believes that a civil or administrative sanctions are likely to result from the inspection. An AIW, however, has its limits DI s can only inspect, not search, a location, and only records required to be kept by DEA regulations may be inspected and copied. But, DI s can, and often do, provide their findings to law enforcement investigators. VI. SEARCH WARRANTS After the covert portion of an investigation is complete, investigators will raid the pain management practice and execute a search warrant, during which they will seize paper documents and mirror image the hard drives of the practice s computers. Among other things, the investigators will target medical files and charts, financial records (such as payment records and ledgers), communications (including e-mails) by and between the targeted doctors and their employees, and employee personnel files. 4 During the search warrant execution, the investigators will attempt to interview office personnel and even the targeted doctors. VII. EXPERT WITNESSES Investigators will provide the patient files and other pertinent records obtained during the search to expert witnesses, typically doctors who are pain management specialists. The government-retained doctors will inevitably testify at trial that, based on their records review, the target doctor was illegally 4 Investigators may attempt to obtain these documents by issuing a Grand Jury or administrative subpoena to the practice. But this is rare because they typically do not want to alert the practice that it is being investigated before the investigation is complete. 4

prescribing drugs for illegitimate purposes. Thus, it is imperative that white collar attorneys who represent doctors and other healthcare professionals in a pill mill case retain as early as possible their own experts who can review the same records and opine that the doctor was engaged in the legitimate practice of medicine, not a criminal enterprise. Indeed, pill mill trials will often be decided by a battle of the experts. White Collar Courier quote of the day: [T]here are continuing tensions between [law enforcement and medical] professionals, especially in the context of drugs. Law enforcement inhabits a professional space in which drugs (including abused prescription drugs) are the enemy: dangerous, deadly, and harmful. Physicians inhabit a professional space in which prescription drugs are useful tools, often helpful, and rarely deadly. These professional spaces converge at controlled substances, most of which have simultaneous potential for causing great harm and providing great benefit. 5 Next Up: Part Four Pill Mill Red Flags and Strategies to Avoid Them To discuss the information further, please contact: Adam Overstreet at aoverstreet@burr.com or the Burr & Forman attorney with whom you regularly work. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. 5 Kelly K. Dineen & James M. DuBois, Between a Rock and a Hard Place: Can Physicians Prescribe Opioids to Treat Pain Adequately While Avoiding Legal Sanctions? 42 AM. J.L. & MED. 7, 26 (2016). 5